CLINICAL_TRIALS
trial_result
· 2024-08-07
Clinical Trial Update: Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Summary
Phase 2 clinical trial update evaluating intermittent dosing of duvelisib in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Results h…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: City of Hope Medical Center | Conditions: Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-08-07